ITRN Q4 2025 Earnings EPS Beats Estimates Stock Rises 316 AbbVie ABBV Q1 2026 Earnings Slight EPS Beat Amid Solid Operational Execution SKYX Q1 2026 Earnings EPS Falls Short of Estimates Amid Ongoing Development Edgewise Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Progress Continues ENR Q1 2026 Earnings Stellar EPS Beat Propels Shares Higher EYPT Q1 2026 Earnings WiderthanExpected Loss as PreCommercial Biotech Continues RD Investment